Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.European Commission (EC) has unveiled a new strategy focused on advancing the development, manufacturing and deployment of Covid-19 vaccines.
EC has committed to help speed-up the development and availability of safe and effective vaccines in a timeframe of 12 to 18 months, and if possible earlier.
This would require a simultaneous focus on clinical trials and scale-up of manufacturing capacity. The strategy calls for a joint approach across the European Union (EU).
One such joint initiative has already been launched in the form of Inclusive Vaccine Alliance (IVA) by France, Germany, Italy and the Netherlands.